Related Experiment Video
Updated: Aug 10, 2026
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Mycotic infections in pediatric surgical patients
1Department of Surgery, State University of New York at Buffalo, Children's Hospital of Buffalo 14222, USA.
Abstract:
Mycotic infections have become an increasingly common problem in immunosuppressed pediatric patients. The management of fungal infections requires not only the recognition of the potential for infection, but also of the types of organisms that can cause infection. The identification of the organ system(s) affected is important in directing therapy. The immature immune system of neonates is partially responsible for some specific diseases and unique management problems. These infants are increasingly stressed to degrees not previously seen in intensive care nurseries and may be on long-term antibiotic therapy for other illnesses. Chemotherapy for malignancy, bone marrow transplants, trauma, and chronic illness increase the risk of immunocompromise and systemic fungal infections. The frequent use of long-term intravascular catheters contributes to the potential for fungal infection in the pediatric population. Therapy now includes administration of topical and/or parenteral antifungal agents and supportive care to the patients. New therapies may well include more potent and safer antifungal agents as well as new ways to enhance the immune response in immunosuppressed patients.
Insights
Fungal infections are a growing concern in immunocompromised children, especially neonates. Effective management requires identifying the causative fungi and affected organs for targeted antifungal therapy and supportive care.
Area of Science:
- Pediatric Infectious Diseases
- Mycology
- Immunocompromised Host
Background:
- Mycotic infections present a significant challenge in pediatric care, particularly among immunocompromised patients.
- Neonates possess immature immune systems, increasing susceptibility to specific fungal diseases and unique management issues.
- Factors such as intensive care, long-term antibiotic use, chemotherapy, bone marrow transplants, trauma, chronic illnesses, and intravascular catheters elevate the risk of systemic fungal infections in children.
Purpose of the Study:
- To highlight the increasing prevalence of fungal infections in immunosuppressed pediatric patients.
- To emphasize the critical need for recognizing potential fungal pathogens and affected organ systems for effective treatment.
- To discuss current and potential future therapeutic strategies for managing pediatric mycotic infections.
Main Methods:
- Review of current literature on pediatric mycotic infections.
- Analysis of risk factors contributing to fungal infections in immunocompromised children.
- Examination of current and emerging treatment modalities.
Main Results:
- Fungal infections are increasingly prevalent in pediatric populations with compromised immune systems.
- Identification of causative organisms and affected organ systems is crucial for successful therapeutic intervention.
- Current therapies involve topical/parenteral antifungal agents and supportive care, with ongoing research into novel, safer antifungals and immunomodulatory approaches.
Conclusions:
- Prompt recognition and accurate diagnosis of fungal infections are vital for managing immunosuppressed pediatric patients.
- Multifaceted treatment strategies, including advanced antifungal agents and immune support, are essential for improving outcomes.
- Continued research into novel therapies is necessary to combat the rising incidence of these infections.
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:28Fungal Phylum Microsporidia
01:27Cryptococcal Meningitis
01:20Candidiasis